Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Estradiol valerate tablets (bujiale)

It is used in combination with progesterone to establish an artificial menstrual cycle to supplement estrogen deficiency mainly related to natural or artificial menopause: vasomotor diseases (hot flashes), reproductive and urinary nutritional diseases (vulvovaginal atrophy, dyspareunia, urinary incontinence) and mental diseases (sleep disorders, weakness). More role
App download minus 10 yuan
Common name:
Estradiol valerate tablets
Product No.:
B14202007142
Approval No.:
Gyzz j20171038 (inquired by the State Drug Administration)
Jianke price:
¥50.00
Product specification:
1mg*21s 1mg*21s+0.2g*60s
Manufacturer:
Bayer medical and health care Co., Ltd. Guangzhou Branch
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Estradiol valerate tablets (bujiale)
Main raw materials Estradiol valerate.
Main role It is used in combination with progesterone to establish an artificial menstrual cycle to supplement estrogen deficiency mainly related to natural or artificial menopause: vasomotor diseases (hot flashes), reproductive and urinary nutritional diseases (vulvovaginal atrophy, dyspareunia, urinary incontinence) and mental diseases (sleep disorders, weakness).
Product specification 1mg*21s
Usage and dosage Oral administration. The dose is adjusted according to the individual, usually one tablet a day. Adjust the dose required by the individual according to the clinical situation: Generally speaking, breast swelling and irritable feeling indicate that the dose is too high. If the selected dose has not alleviated the symptoms of estrogen deficiency, the dose must be increased. (see the inner packaging manual for details)
manufacturing enterprise Bayer medical and health care Co., Ltd. Guangzhou Branch
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Estradiol valerate tablets (bujiale)

[common name] Estradiol valerate tablets

[specification and model] 1mg*21s

[manufacturer] Bayer medical and health care Co., Ltd. Guangzhou Branch

[drug type] Western medicine

[approval No.] Gyzz j20171038

[validity period] 60 months

[functional indications] It is used in combination with progesterone to establish an artificial menstrual cycle to supplement estrogen deficiency mainly related to natural or artificial menopause: vasomotor diseases (hot flashes), reproductive and urinary nutritional diseases (vulvovaginal atrophy, dyspareunia, urinary incontinence) and mental diseases (sleep disorders, weakness).

[usage and dosage] Oral administration. The dose is adjusted according to the individual, usually one tablet a day. Adjust the dose required by the individual according to the clinical situation: Generally speaking, breast swelling and irritable feeling indicate that the dose is too high. If the selected dose has not alleviated the symptoms of estrogen deficiency, the dose must be increased. (see the inner packaging manual for details)

[adverse reactions] Common adverse reactions include weight gain, weight loss, headache, abdominal pain, nausea, rash, pruritus, uterine / vaginal bleeding, including drip bleeding. (see the inner packaging manual for details)

[precautions] Before starting treatment, a comprehensive and thorough medical and gynecological examination (including breast examination and cervical cell smear) should be carried out. 2 the drug should be stopped immediately in case of the following conditions: the first occurrence of migraine or frequent onset of rare severe headache, sudden sensory impairment (such as visual or auditory impairment), pre-existing indications of thrombophlebitis or thromboembolism (such as abnormal leg pain or swelling, unexplained tingling during breathing or cough), chest pain and tightness, jaundice, hepatitis, systemic pruritus The number of seizures increased and blood pressure increased significantly. 3 if you take other drugs regularly (such as barbiturates, butazone, hydantoin, rifampicin, ampicillin), you should tell the doctor, because these drugs can interfere with the effect of this product. In addition, this product will change the demand for oral hypoglycemic drugs or insulin. If uterine bleeding occurs in very few cases, the patient must consult a doctor to find out the cause. 5 if the patient has the following diseases, he must inform the doctor, such as diabetes, hypertension, varicose veins, ossifosis, multiple sclerosis, epilepsy, porphyria, foot and foot convulsions, and small chorea. All patients with such diseases and those with history of phlebitis must be treated with strict clinical supervision. Individual patients with benign or malignant liver tumors may have life-threatening intraperitoneal bleeding after taking hormone drugs (this product also contains such substances). Therefore, if abnormal epigastric symptoms do not disappear within a short time, you should tell the doctor. 7 beyond all dispute, the benefits of estrogen drugs have been scientifically proven. However, recent observations suggest that prolonged non antagonistic estrogen therapy in menopause may increase the incidence rate of endometrial cancer. Because this suspicious risk is not completely excluded, endometrial hyperplasia should be avoided by non antagonistic estrogen therapy. For external administration of progesterone drugs, any patient shall abide by the dose prescribed by the doctor, including the doctor's advice and course of treatment on intermittent medication, and shall abide by the agreement of gynecological review. 8 this product should be stopped before operation (6 weeks in advance) and limb fixation (such as after accident). (see the inner packaging instructions for details) please read the instructions carefully and follow the doctor's instructions.

[taboo] Hormone replacement therapy (HRT) should not be started when any of the conditions listed below exist. If any of the following conditions occurs during HRT administration, the drug should be stopped immediately. ·Pregnancy and lactation ·Undiagnosed vaginal bleeding Known or suspected breast cancer ·Precancerous lesions or malignancies known or suspected to be affected by sex hormones ·Existing or previous history of liver tumor (benign or malignant) ·Severe liver disease ·Acute arterial thromboembolism (e.g. myocardial infarction, stroke) ·Active deep venous thrombosis, thromboembolic diseases, or a documented history of these diseases ·High risk factors of venous or arterial thrombosis ·Severe hypertriglyceridemia ·Allergic to active ingredients or any excipients

[listing Permit Holder] Bayer medical and health care Co., Ltd. Guangzhou Branch

[packaging unit] box

[main ingredients] Estradiol valerate.

[character] Pale yellow sugar coated tablets, white after removing the sugar coating.

[applicable population] Adult, female

[medication for pregnant and lactating women] Estradiol valerate cannot be used in pregnant or lactating women. If pregnant during estradiol valerate treatment, treatment should be stopped immediately. A large-scale epidemiological study of steroid hormones used in contraception and hormone replacement therapy shows that women who use these hormones before pregnancy have no increased risk of neonatal birth defects, and accidental use of these drugs in early pregnancy has no teratogenic effect. A small amount of sex hormones can be secreted in human milk.

[medication for children] Estradiol valerate tablets should not be used in children.

[medication for elderly patients] Elderly patients take it under the guidance of doctors.

[storage] seal up.

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Estradiol valerate tablets (bujiale)

    ¥50.00

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!